The Effects of Immunomodulatory Molecule- Lipoxin A4- on The Physiology of Cystic Fibrosis Human Bronchial Epithelium | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 13, Volume 70, Issue 5, January 2018, Page 786-790 PDF (507.58 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.12816/0043983 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohammad Sindi  ; Magdalena Mroz Mroz
| ||||
| Faculty of Molecular Medicine, Beaumont Hospital | ||||
| Abstract | ||||
| ABSTRACT Cystic fibrosis (CF) is a disease characterised by the depletion of Airway Surface Liquid (ASL) height. Lipoxin A4 was found to be effective in restoring ASL back to normal by acting on ENaC. The signalling mechanisms involved in lipoxin effect were investigated by testing the action of a calcium chelator (Bapta-AM) and Protein kinase C inhibitor (GF 109203X) on NuLi-1 and CuFi-1 cells. Drug’s efficacy was monitored by conducting Ussing chamber experiments and confocal microscopy. Results showed that calcium has a major contribution to the lipoxin A4 effects while PKC has a limited role. However, our data might lack accuracy due to shortage of time to conduct more experiments. | ||||
| Keywords | ||||
| CFTR; Cystic fibrosis; genetic mutations; human bronchial; Lipoxin A4; human bronchial epithelium | ||||
|
Statistics Article View: 147 PDF Download: 192 |
||||
